Qube Research & Technologies (QRT)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-151,947
Closed -$10.6M 3653
2025
Q4
$10.1M Sell
151,947
-145,938
-49% -$9.43M 0.01% 1337
2025
Q3
$20M Sell
297,885
-1,333,458
-82% -$106M 0.02% 890
2025
Q2
$142M Buy
1,631,343
+931,998
+133% +$73.1M 0.14% 166
2025
Q1
$47.8M Sell
699,345
-382,590
-35% -$31.2M 0.06% 423
2024
Q4
$84.1M Sell
1,081,935
-638,178
-37% -$47.2M 0.11% 227
2024
Q3
$115M Buy
1,720,113
+1,484,112
+629% +$122M 0.17% 122
2024
Q2
$26.8M Buy
236,001
+226,395
+2,357% +$28.6M 0.04% 506
2024
Q1
$1.33M Buy
9,606
+1,247
+15% +$157K ﹤0.01% 1973
2023
Q4
$1.04M Sell
8,359
-437,893
-98% -$44.7M ﹤0.01% 1903
2023
Q3
$41.6M Buy
446,252
+331,708
+290% +$37.4M 0.11% 229
2023
Q2
$14.7M Sell
114,544
-101,030
-47% -$12.2M 0.05% 419
2023
Q1
$25M Buy
+215,574
New +$24.1M 0.11% 199
2022
Q3
Sell
-297,382
Closed -$22.2M 2607
2022
Q2
$22.2M Buy
+297,382
New +$27.1M 0.16% 156
2022
Q1
Sell
-89,828
Closed -$12.1M 2573
2021
Q4
$12.1M Buy
+89,828
New +$12.9M 0.09% 273
2020
Q4
Sell
-112,524
Closed -$11.6M 1894
2020
Q3
$11.6M Sell
112,524
-75,600
-40% -$7.9M 0.17% 140
2020
Q2
$19.1M Buy
+188,124
New +$16.8M 0.28% 69

Other funds holding DXCM

Qube Research & Technologies (QRT)'s DXCM Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of DexCom (DXCM) in Q1 2026, closing a stake of 151,947 shares — an estimated $10.6M sold.

Qube Research & Technologies (QRT) first reported a position in DXCM in Q2 2020 and held it in 16 quarters. The position peaked at $142M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 151,947 DexCom shares in Q1 2026, an estimated $10.6M.
  • Qube Research & Technologies (QRT) first reported a position in DexCom in Q2 2020 and held it in 16 quarters.
  • Qube Research & Technologies (QRT)'s DexCom position peaked at $142M in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.